FDA
approval
· 2022-04-29
FDA Approved: FEMYNOR — Supplemental Application (Amneal Pharmaceuticals NY LLC)
Summary
FDA approves a supplemental application for FEMYNOR, a generic oral contraceptive containing norgestimate and ethinyl estradiol, from Amneal Pharmaceuticals NY …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL)